Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[SNPs associated with adverse effects].

Gan to kagaku ryoho. Cancer & chemotherapy - 1 Nov 2005

Isomura Minoru, Miki Yoshio

Abstract excerpt

In recent years, pharmacogenomics have received much attention from the increased expectations for so-called order-made medicine. It is experientially clear that inter-individual differences exist in the degree of efficacy and occurrence of adverse effects. These inter-individual differences are observed not only among anticancer chemotherapeutics but in almost all drugs. Several studies have revealed that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Camptothecin
Share to Fluorouracil

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucuronosyltransferase

Share to Irinotecan

Share to Methotrexate

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Pharmacogenetics

Source

Identifiers

PMID: 16282725

Genes

DPYD
MTHFR
TPMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[SNPs associated with adverse effects].PMID 16282725Read ↗

Pharmacogenetics of Drugs Used in the Treatment of CancersSemantic proximity Read ↗

[Correlation between single nucleotide polymorphisms and hematological malignancies].Semantic proximity Read ↗

[Pharmacogenetics of anti-cancer drugs].Semantic proximity Read ↗

Genetic Risk Factors for Adverse Drug ReactionsSemantic proximity Read ↗

Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases.Semantic proximity Read ↗

How to Consider Rare Genetic Variants in Personalized Drug Therapy.Semantic proximity Read ↗

[Pharmacogenetics of anticancer drugs].Semantic proximity Read ↗

Genetic determinants of cancer drug efficacy and toxicity: practical considerations and perspectives.Semantic proximity Read ↗

Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer.Semantic proximity Read ↗

Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.Semantic proximity Read ↗

Germline oncopharmacogenetics, a promising field in cancer therapy.Semantic proximity Read ↗

Update on pharmacogenetics in cancer chemotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.